Afficher la notice abrégée

The Molecular and Cellular Basis for Parkinson's Disease

dc.contributor.authorMüller, Thomas*
dc.date.accessioned2021-02-11T20:02:36Z
dc.date.available2021-02-11T20:02:36Z
dc.date.issued2019*
dc.date.submitted2019-12-09 11:49:15*
dc.identifier42580*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/53820
dc.description.abstractThe focus on dopamine-sensitive motor symptoms, in association with the improvement of motor complications in the heterogeneous disease entity Parkinson's disease, has led to a certain standstill in research. This Special Issue provides new concepts and new ideas on the pathogenesis, genetics, and clinical maintenance of Parkinson's disease and related disorders. Not only new experimental findings, but also clinical outcomes, case series, and research on alternative, non-pharmacological therapies are included. The objective is to bridge the currently increasing gap between experimental and clinical research on Parkinson's disease and related disorders.*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRC321-571*
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.othermicroRNAs*
dc.subject.otherdisease-modifying effects*
dc.subject.otherSH-SY5Y*
dc.subject.otherinpatient treatment*
dc.subject.othersphingolipids*
dc.subject.otherneurodegeneration*
dc.subject.othermagnetic resonance spectroscopy*
dc.subject.otherMO3.13*
dc.subject.otherschizophrenia*
dc.subject.otherepigenetics*
dc.subject.otherlong-chain acylcarnitine*
dc.subject.othermolecular mimicry*
dc.subject.othercurli*
dc.subject.othermultimodal complex treatment*
dc.subject.otherchlorogenic acid*
dc.subject.otherglycerophospholipids*
dc.subject.othercaffeic acid*
dc.subject.otherlipoproteins*
dc.subject.othermyenteric plexus*
dc.subject.otherneurometabolites*
dc.subject.otherHOG*
dc.subject.otherimmature oligodendrocyte*
dc.subject.otherautophagy*
dc.subject.otheroligodendrocyte*
dc.subject.otherhypochlorite*
dc.subject.otheralpha-synuclein*
dc.subject.othermicrobiome*
dc.subject.otherglucocerebrosidase*
dc.subject.otherLewy Body Dementia*
dc.subject.otherbrain iron*
dc.subject.othermesenchymal stem cells*
dc.subject.otherfatty acid ?-oxidation*
dc.subject.otherGABA*
dc.subject.otherenteric glial cell*
dc.subject.othergut-brain axis*
dc.subject.othermicrobiota*
dc.subject.otherREM sleep behavior disorders*
dc.subject.otherredox cycling*
dc.subject.othermagnetic resonance imaging*
dc.subject.otherdifferentiation*
dc.subject.other?-synuclein-mediated pathology*
dc.subject.otherParkinson disease*
dc.subject.otherGaucher’s disease*
dc.subject.othermetallothionein*
dc.subject.other[123I]FP-CIT-SPECT*
dc.subject.otherdopaminergic neuron*
dc.subject.othermature oligodendrocyte*
dc.subject.otherglycerolipids*
dc.subject.otherspectroscopy*
dc.subject.otherneuroinflammation*
dc.subject.otherexosomes*
dc.subject.otherimmunotherapy*
dc.subject.otherDNA methylation*
dc.subject.othersterol lipids*
dc.subject.othernigral cells*
dc.subject.othercell line*
dc.subject.othercysteinyl-dopamine*
dc.subject.othermyelin*
dc.subject.otherparkinsonisms*
dc.subject.othermultiple sclerosis*
dc.subject.otherrotenone*
dc.subject.otherbrain*
dc.subject.otherfatty acyls*
dc.subject.otherKrabbe’s disease*
dc.subject.otherneuroprotection*
dc.subject.otherDAT*
dc.subject.othermotor dysfunction*
dc.subject.othersecretome*
dc.subject.othermultiprofessional therapy*
dc.subject.otherParkinson’s disease*
dc.subject.otheroxidative stress*
dc.subject.otheralpha-Synuclein*
dc.titleThe Molecular and Cellular Basis for Parkinson's Disease*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03921-549-2*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039215492*
oapen.relation.isbn9783039215485*
oapen.pages230*
oapen.edition1st*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by-nc-nd/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by-nc-nd/4.0/